Are results from VARSITY applicable to real world? Adalimumab versus vedolizumab as first line biological in moderate-to-severe IBD

被引：0
|
作者：
Moens, A. [1 ,2 ]
Verstockt, B. [1 ,2 ]
Alsoud, D. [2 ]
Sabino, J. [1 ,2 ]
Ferrante, M. [1 ,2 ]
Vermeire, S. [1 ,2 ]
机构：
[1] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.433
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P309
引用
收藏
页码：S336 / S337
页数：4
相关论文
共 50 条
  • [21] Vedolizumab is associated with longer drug sustainability compared to infliximab in moderate-to-severe Ulcerative Colitis: a real-world cohort study
    Konikoff, T.
    Yanai, H.
    Banai, H.
    Avni-Biron, I.
    Snir, Y.
    Broitman, L.
    Barkan, R.
    Checholin, L.
    Dotan, I.
    Ollech, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I463 - I464
  • [22] First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq
    Assan, Florence
    Tubach, Florence
    Arlegui, Hugo
    Viguier, Manuelle
    Beylot-Barry, Marie
    Dupuy, Alain
    Beneton, Nathalie
    Joly, Pascal
    Jullien, Denis
    Mahe, Emmanuel
    Paul, Carle
    Richard, Marie-Aleth
    Bachelez, Herve
    Giboin, Caroline
    Chosidow, Olivier
    Sbidian, Emilie
    DERMATOLOGY, 2021, 237 (03) : 338 - 346
  • [23] Adalimumab for moderate to severe hidradentitis suppurativa: Real-world data from a tertiary clinic
    Sharif, Jennifer
    Ferguson, Felicity J.
    McMullen, Emma
    Fitzgerald, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB16 - AB16
  • [24] The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium
    Dulai, Parambir S.
    Singh, Siddharth
    Jiang, Xiaoqian
    Peerani, Farhad
    Narula, Neeraj
    Chaudrey, Khadija
    Whitehead, Diana
    Hudesman, David
    Lukin, Dana
    Swaminath, Arun
    Shmidt, Eugenia
    Wang, Shuang
    Boland, Brigid S.
    Chang, John T.
    Kane, Sunanda
    Siegel, Corey A.
    Loftus, Edward V.
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1147 - 1155
  • [25] "Interim results from the PEDISTAD Real-World Registry by Paller et al"-First results from the German TREATkids registry for children and adolescents with moderate-to-severe atopic dermatitis
    Ott, Hagen
    Abraham, Susanne
    Kind, Barbara
    Haufe, Eva
    Weidinger, Stephan
    Werfel, Thomas
    Schmitt, Jochen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : e31 - e33
  • [26] Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study
    Gottlieb, Alice B.
    Merola, Joseph F.
    Reich, Kristian
    Behrens, Frank
    Nash, Peter
    Bao, Weibin
    Pellet, Pascale
    Pricop, Luminita
    McInnes, Iain B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB92 - AB92
  • [27] Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan
    Chen, Yu-Chen
    Huang, Yi-Ting
    Yang, Chao-Chun
    Lai, Edward Chia-Cheng
    Liu, Cheng-Han
    Hsu, Chao-Kai
    Wong, Tak-Wah
    Chao, Sheau-Chiou
    Sheu, Hamm-Ming
    Lee, Chaw-Ning
    PLOS ONE, 2020, 15 (12):
  • [28] Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic
    Smetanova, Alzbeta
    Marques, Emanuel
    Kojanova, Martina
    Arenberger, Petr
    Strosova, Daniela
    Fialova, Jorga
    Arenbergerova, Monika
    DERMATOLOGIC THERAPY, 2023, 2023
  • [29] Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab
    Reich, Kristian
    Foley, Peter
    Han, Chenglong
    McElligott, Sean
    Muser, Erik
    Li, Nan
    Armstrong, April W.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (06) : 617 - 623
  • [30] Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study
    Rivera, Raquel
    Vilarrasa, E.
    Ribera, M.
    Roe, E.
    Kueder-Pajares, T.
    Zayas, A. I.
    Martinez-Molina, L.
    Mataix Diaz, J.
    Rodriguez-Nevado, I. M.
    Usero-Barcena, T.
    de la Mano, D.
    Garcia-Donoso, C.
    Olveira, A.
    Guinea, G.
    Martin-Vazquez, V.
    Ferran, M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1329 - 1338
12345